 |
2016-02-28 01:07:33 Not in at the ●●●●●● ●●●●●●oid 50 mcg ●●●●●● loss ●●●●●●n Most new deals in Europe meet these risk ●●●●●●●●●●●●●●●●●●nts, but they are ●●●●●●ed to ●●●●●● new issue CLO●●●●●● by ●●●●●●cting the ●●●●●● to ●●●●●●rs that can put up 5%of the deal from their own funds, ●●●●●● than ●●●●●● funds. OneCLO ●●●●●●r, GoldenTree Asset M●●●●●●ent, has ●●●●●●y done aeuro-●●●●●●nated CLO which ●●●●●●s said it ●●●●●● to US andKorean ●●●●●●ors, ●●●●●●ng the need to ●●●●●● with the rules. ●●●●●●ex ●●●●●●s 5mg brand "I've seen lots of ●●●●●●ty ●●●●●●s ●●●●●● this is a ●●●●●●ng issue," Burton told the Daily News. "But it's based on ●●●●●●●●●●●● that we don't see and only hear about ⦠This issue is ●●●●●● hard to pin down. The ●●●●●●ry ●●●●●●les with this on many ●●●●●●." |